Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garvey, W. T.
Right arrow Articles by Burns, D. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garvey, W. T.
Right arrow Articles by Burns, D. K.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 46, Issue 3 444-450, Copyright © 1997 by American Diabetes Association


ARTICLES

Muscle Rad expression and human metabolism: potential role of the novel Ras-related GTPase in energy expenditure and body composition

WT Garvey, L Maianu, A Kennedy, P Wallace, E Ganaway, LL Hamacher, DP Yarnall, JM Lenhard and DK Burns
Department of Medicine, Medical University of South Carolina, Charleston 29425, USA. garveywt@musc.edu

Ras associated with diabetes (Rad), a new ras-related GTPase, was recently identified by subtractive cloning as an mRNA in skeletal muscle that is overexpressed in NIDDM. To better understand its metabolic significance, we measured skeletal muscle Rad expression in well-characterized insulin sensitive (IS) and insulin resistant (IR) subjects with normal glucose tolerance and in untreated NIDDM patients. We found no differences in expression of Rad mRNA levels among IS, IR, and NIDDM groups using a ribonuclease protection assay (0.22 +/- 0.06, 0.13 +/- 0.01, and 0.16 +/- 0.02 relative units, respectively; NS) and no differences in Rad protein expression using a specific anti-peptide Rad antibody (1.05 +/- 0.18, 1.14 +/- 0.08, and 1.08 +/- 0.21 units/mg protein, respectively; NS). However, Rad protein levels were positively correlated with BMI (r = 0.43, P = 0.03) and percentage body fat (r = 0.55, P < 0.005), two independent measures of obesity, and negatively correlated with resting metabolic rate (r = 0.49, P = 0.01). In multiple regression analyses, percentage body fat and resting metabolic rate independently accounted for 30 and 10% of individual variability in muscle Rad protein expression. In conclusion, Rad expression in skeletal muscle is not altered as a function of insulin resistance or NIDDM in humans. However, these data, for the first time, implicate a role for Rad in regulating body composition and energy expenditure and provide a framework for studies designed to elucidate Rad's cellular functions.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
J. Ilany, P. J. Bilan, S. Kapur, J. S. Caldwell, M.-E. Patti, A. Marette, and C. R. Kahn
Overexpression of Rad in muscle worsens diet-induced insulin resistance and glucose intolerance and lowers plasma triglyceride level
PNAS, March 21, 2006; 103(12): 4481 - 4486.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
K. Martin, P. Wallace, P. F. Rust, and W. T. Garvey
Estimation of Resting Energy Expenditure Considering Effects of Race and Diabetes Status
Diabetes Care, June 1, 2004; 27(6): 1405 - 1411.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Lin, A. Sahai, S. S. Chugh, X. Pan, E. I. Wallner, F. R. Danesh, J. W. Lomasney, and Y. S. Kanwar
High Glucose Stimulates Synthesis of Fibronectin via a Novel Protein Kinase C, Rap1b, and B-Raf Signaling Pathway
J. Biol. Chem., October 25, 2002; 277(44): 41725 - 41735.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. M. Willi, A. Kennedy, P. Wallace, E. Ganaway, N. L. Rogers, and W. T. Garvey
Troglitazone Antagonizes Metabolic Effects of Glucocorticoids in Humans: Effects on Glucose Tolerance, Insulin Sensitivity, Suppression of Free Fatty Acids, and Leptin
Diabetes, October 1, 2002; 51(10): 2895 - 2902.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P.-H. Ducluzeau, N. Perretti, M. Laville, F. Andreelli, N. Vega, J.-P. Riou, and H. Vidal
Regulation by Insulin of Gene Expression in Human Skeletal Muscle and Adipose Tissue: Evidence for Specific Defects in Type 2 Diabetes
Diabetes, May 1, 2001; 50(5): 1134 - 1142.
[Abstract] [Full Text]


Home page
NEJMHome page
P. R. Shepherd and B. B. Kahn
Glucose Transporters and Insulin Action -- Implications for Insulin Resistance and Diabetes Mellitus
N. Engl. J. Med., July 22, 1999; 341(4): 248 - 257.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
L. A. Sonna, S. L. Gaffin, R. E. Pratt, M. L. Cullivan, K. C. Angel, and C. M. Lilly
Molecular Biology of Thermoregulation: Selected Contribution: Effect of acute heat shock on gene expression by human peripheral blood mononuclear cells
J Appl Physiol, May 1, 2002; 92(5): 2208 - 2220.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1997 by the American Diabetes Association.